{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:16:07Z","timestamp":1789953367561,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["18-29-01009"],"award-info":[{"award-number":["18-29-01009"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gene.2018.08.069","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T17:20:08Z","timestamp":1535563208000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy"],"prefix":"10.1016","volume":"679","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-6846","authenticated-orcid":false,"given":"Aleksei A.","family":"Stepanenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir P.","family":"Chekhonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2018.08.069_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-398342-8.00004-5","article-title":"Chapter four\u2013design of improved oncolytic adenoviruses","volume":"115","author":"Alemany","year":"2012","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2015.194","article-title":"Development of novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs","volume":"24","author":"Alonso-Padilla","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0020","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/138920112800958823","article-title":"Mining the adenovirus \u201cvirome\u201d for systemic oncolytics","volume":"13","author":"Barry","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.gene.2018.08.069_bb0025","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.162.9.5049","article-title":"Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression","volume":"162","author":"Bennett","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.08.069_bb0030","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.gene.2018.08.069_bb0035","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.febslet.2013.01.036","article-title":"Studying the RNA silencing pathway with the p19 protein","volume":"587","author":"Danielson","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2018.08.069_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1743-422X-8-162","article-title":"Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells","volume":"8","author":"van den Hengel","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.gene.2018.08.069_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145272","article-title":"A multi targeting conditionally replicating adenovirus displays enhanced oncolysis while maintaining expression of immunotherapeutic agents","volume":"10","author":"Dobbins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.08.069_bb0050","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/JVI.74.13.6147-6155.2000","article-title":"Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein","volume":"74","author":"Doronin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/JVI.45.1.185-191.1983","article-title":"Sequence arrangement and protein coding capacity of the adenovirus type 2 \u201ci\u201d leader","volume":"45","author":"Falvey","year":"1983","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0060","article-title":"HAdV protein V core protein is targeted by the host SUMOylation machinery to limit essential viral functions","volume":"92","author":"Freudenberger","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.molimm.2010.10.017","article-title":"Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules","volume":"48","author":"Fu","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.gene.2018.08.069_bb0070","doi-asserted-by":"crossref","first-page":"17631","DOI":"10.1074\/jbc.M110.212050","article-title":"Adenovirus E3-19K proteins of different serotypes and subgroups have similar, yet distinct, immunomodulatory functions toward major histocompatibility class I molecules","volume":"286","author":"Fu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.08.069_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2018.03.006","article-title":"Armed oncolytic viruses: a kick-start for anti-tumor immunity","author":"de Graaf","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.gene.2018.08.069_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1875037001003020024","article-title":"Adenovirus release from the infected cell as a key factor for adenovirus oncolysis","volume":"3","author":"Gros","year":"2010","journal-title":"Open Gene Ther. J."},{"key":"10.1016\/j.gene.2018.08.069_bb0085","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1158\/0008-5472.CAN-08-1145","article-title":"Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency","volume":"68","author":"Gros","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0090","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1517\/14712598.2015.1044433","article-title":"Arming oncolytic viruses to leverage antitumor immunity","volume":"15","author":"de Gruijl","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00251-017-1001-y","article-title":"Missing or altered self: human NK cell receptors that recognize HLA-C","volume":"69","author":"Hilton","year":"2017","journal-title":"Immunogenetics"},{"key":"10.1016\/j.gene.2018.08.069_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/biomedicines4030023","article-title":"Showing the way: oncolytic adenoviruses as chaperones of immunostimulatory adjuncts","volume":"4","author":"Huang","year":"2016","journal-title":"Biomedicine"},{"key":"10.1016\/j.gene.2018.08.069_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/vim.2016.0145","article-title":"Presentation of a conserved adenoviral epitope on HLA-C*0702 allows evasion of natural killer but not T cell responses","volume":"30","author":"Keib","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.gene.2018.08.069_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4143\/crt.2003.35.5.425","article-title":"Increased cytopathic effect of replicating adenovirus expressing adenovirus death protein","volume":"35","author":"Kim","year":"2003","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.gene.2018.08.069_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omto.2017.02.002","article-title":"The sequence of Delta24-RGD and TMZ administration in malignant glioma affects the role of CD8(+)T cell anti-tumor activity","volume":"5","author":"Kleijn","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.gene.2018.08.069_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.gene.2018.08.069_bb0125","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djt184","article-title":"MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells","volume":"105","author":"Leone","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gene.2018.08.069_bb0130","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nsmb.2396","article-title":"Crystal structure of adenovirus E3-19K bound to HLA-A2 reveals mechanism for immunomodulation","volume":"19","author":"Li","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.gene.2018.08.069_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/1078-0432.CCR-16-0477","article-title":"The efficacy of oncolytic adenovirus is mediated by T-cell responses against virus and tumor in Syrian hamster model","volume":"23","author":"Li","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/08830180490265556","article-title":"Functions and mechanisms of action of the adenovirus E3 proteins","volume":"23","author":"Lichtenstein","year":"2004","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.gene.2018.08.069_bb0145","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.4049\/jimmunol.178.7.4567","article-title":"Allele- and locus-specific recognition of class I MHC molecules by the immunomodulatory E3-19K protein from adenovirus","volume":"178","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.08.069_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep27598","article-title":"Dicer functions as an antiviral system against human adenoviruses via cleavage of adenovirus-encoded noncoding RNA","volume":"6","author":"Machitani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.08.069_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1158\/1535-7163.MCT-16-0383","article-title":"Enhanced oncolytic activities of the telomerase-specific replication-competent adenovirus expressing short-hairpin RNA against dicer","volume":"16","author":"Machitani","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0160","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1128\/JVI.02251-07","article-title":"Adenovirus E3\/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins a and B","volume":"82","author":"McSharry","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/MCB.14.1.437","article-title":"Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs","volume":"14","author":"Nordqvist","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gene.2018.08.069_bb0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1083\/jcb.132.4.511","article-title":"Activation of transcription factor NF-kappaB by the adenovirus E3\/19K protein requires its ER retention","volume":"132","author":"Pahl","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.gene.2018.08.069_bb0175","doi-asserted-by":"crossref","first-page":"89391","DOI":"10.18632\/oncotarget.20810","article-title":"Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma","volume":"8","author":"Panek","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2018.08.069_bb0180","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1128\/JVI.00935-14","article-title":"Isolation and characterization of the DNA and protein binding activities of adenovirus core protein V","volume":"88","author":"P\u00e9rez-Vargas","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data","volume":"8","author":"Pesonen","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.gene.2018.08.069_bb0190","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3389\/fmicb.2017.01324","article-title":"MicroRNAs as important players in host\u2013adenovirus interactions","volume":"8","author":"Piedade","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.gene.2018.08.069_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/mt.2011.159","article-title":"Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers","volume":"20","author":"Puig-Saus","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/cgt.2013.85","article-title":"The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model","volume":"21","author":"Puig-Saus","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep01363","article-title":"RNAi suppressor P19 can be broadly exploited for enhanced adenovirus replication and microRNA knockdown experiments","volume":"3","author":"Rauschhuber","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2018.08.069_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006013","article-title":"Genome-wide estimation of the spontaneous mutation rate of human adenovirus 5 by high-Fidelity deep sequencing","volume":"12","author":"Risso-Ballester","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.gene.2018.08.069_bb0215","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/gt.2015.41","article-title":"Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity","volume":"22","author":"Rodr\u00edguez-Garc\u00eda","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","article-title":"Recent advances in oncolytic adenovirus therapies for cancer","volume":"21","author":"Rosewell Shaw","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrmicro1395","article-title":"The Tombusvirus-encoded P19: from irrelevance to elegance","volume":"4","author":"Scholthof","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.gene.2018.08.069_bb0230","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1128\/JVI.68.9.5423-5432.1994","article-title":"Conserved cysteine residues within the E3\/19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens","volume":"68","author":"Sester","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4049\/jimmunol.0902343","article-title":"Conserved amino acids within the adenovirus 2 E3\/19K protein differentially affect downregulation of MHC class I and MICA\/B proteins","volume":"184","author":"Sester","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.08.069_bb0240","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/JVI.03391-12","article-title":"The transmembrane domain of the adenovirus E3\/19K protein acts as an endoplasmic reticulum retention signal and contributes to intracellular sequestration of major histocompatibility complex class I molecules","volume":"87","author":"Sester","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0245","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01154-16","article-title":"Adenovirus early proteins and host sumoylation","volume":"7","author":"Sohn","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.gene.2018.08.069_bb0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/JVI.64.2.551-558.1990","article-title":"The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of L1 mRNAs","volume":"64","author":"Soloway","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0255","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3171\/foc.2006.20.4.1","article-title":"Oncolytic adenoviral therapy for glioblastoma multiforme","volume":"20","author":"Sonabend","year":"2006","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.gene.2018.08.069_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2018.08.012","article-title":"Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: focus on fiber chimerism and mosaicism, hexon and pIX","author":"Stepanenko","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0265","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.gene.2015.05.065","article-title":"HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution","volume":"569","author":"Stepanenko","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.08.069_bb0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.gene.2015.08.009","article-title":"Pitfalls of the MTT assay: direct and off-target effects of inhibitors can result in over\/underestimation of cell viability","volume":"574","author":"Stepanenko","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.08.069_bb0275","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/JVI.80.4.2000-2012.2006","article-title":"Genetic identification of adenovirus type 5 genes that influence viral spread","volume":"80","author":"Subramanian","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0280","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/JVI.57.3.848-856.1986","article-title":"Biosynthesis of adenovirus type 2 i-leader protein","volume":"57","author":"Symington","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0285","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/viro.1996.0295","article-title":"The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with ADP mutants","volume":"220","author":"Tollefson","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.gene.2018.08.069_bb0290","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1128\/JVI.77.14.7764-7778.2003","article-title":"Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells","volume":"77","author":"Tollefson","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0295","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/v2091844","article-title":"Increasing the efficacy of oncolytic adenovirus vectors","volume":"2","author":"Toth","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.gene.2018.08.069_bb0300","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1158\/1078-0432.CCR-12-0979","article-title":"A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity","volume":"18","author":"Tysome","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0305","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/nar\/gkq1258","article-title":"Directed adenovirus evolution using engineered mutator viral polymerases","volume":"39","author":"Uil","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0310","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.gendis.2014.09.009","article-title":"Oncolytic adenoviruses: a thorny path to glioma cure","volume":"1","author":"Ulasov","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.gene.2018.08.069_bb0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virusres.2015.06.018","article-title":"Adenovirus VA RNA: an essential pro-viral non-coding RNA","volume":"212","author":"Vachon","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.gene.2018.08.069_bb0320","article-title":"Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2018.08.069_bb0325","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/JVI.77.4.2640-2650.2003","article-title":"Developing novel oncolytic adenoviruses through bioselection","volume":"77","author":"Yan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2018.08.069_bb0330","first-page":"13, 1","article-title":"Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy","author":"Yoon","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.gene.2018.08.069_bb0335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.cgt.7700769","article-title":"ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis","volume":"12","author":"Yun","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.gene.2018.08.069_bb0340","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11262-017-1487-2","article-title":"Getting genetic access to natural adenovirus genomes to explore vector diversity","volume":"53","author":"Zhang","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.gene.2018.08.069_bb0345","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2004.06.007","article-title":"Overexpression of adenovirus E3-11.6K protein induces cell killing by both caspase-dependent and caspase-independent mechanisms","volume":"326","author":"Zou","year":"2004","journal-title":"Virology"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918309314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918309314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T17:40:10Z","timestamp":1693849210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918309314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":69,"alternative-id":["S0378111918309314"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.069","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}